Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$249.65 ▲ +5.60
(+2.30%)
MKT CAP: $36.90B • VOL: 1.16M
52W L $149 52W H $259
DISCLOSED BUY FLOW
$0
DISCLOSED SELL FLOW
$0
13F HEDGE FUND FILINGS
0 DISCLOSURES
CONGRESSIONAL STOCK ACT
0 FILINGS
BIIB // SEC FORM 4 INSIDERS, 13F WHALES & POLITICIAN LEDGER (OWN <GO>)
WHALE DIRECTORY <13F>
| FILING DATE | FILER / INSTITUTION | CATEGORY | ACTION | SHARES | EXEC PRICE | TOTAL VALUE | DOSSIER |
|---|---|---|---|---|---|---|---|
| 2025-02-14 | Citadel Advisors LLC (13F-HR) Institutional Investment Manager | HEDGE_FUND | BUY | 425.0K | $239.66 | $101.9M | TRACK <GO> |
| 2025-02-04 | Executive Officer Form 4 Trust EVP & Chief Financial Officer | INSIDER | SELL | 18.5K | $252.15 | $4.7M | TRACK <GO> |
| 2025-01-28 | Renaissance Technologies LLC 13F Quantitative Holdings | HEDGE_FUND | BUY | 190.0K | $234.67 | $44.6M | TRACK <GO> |